# Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers

> **NCT00235196** · PHASE4 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 48 (—)

## Conditions studied

- Foot Ulcer

## Interventions

- **DEVICE:** Collagen ORC Antimicrobial Matrix (CAM)

## Key facts

- **NCT ID:** NCT00235196
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 48 (—)
- **Last updated:** 2006-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235196, "Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00235196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*